首页> 外文会议>International Conference on Remote Sensing, Environment and Transportation Engineering >Rehabilitation of Allitridi on Homocysteinemia Induced Injury of Endothelin and Nitrogen Oxide in Rats
【24h】

Rehabilitation of Allitridi on Homocysteinemia Induced Injury of Endothelin and Nitrogen Oxide in Rats

机译:血症对大鼠内皮素和氮氧化物损伤的Allitridi康复

获取原文

摘要

The step-up level of serum homocysteine (Hcy) in blood is an independent risk factor for vascular disease, such as atherosclerosis. Low and moderate rise in Hcy can increase the death risk to patients with cardiovascular and cerebrovascular diseases by four to six times. In the development of coronary heart disease (CHD), relative risk of hyperhomocysteinemia is 23.9, which is far higher than other factors, such as hypertensive disease and hyperlipemia disease. Moreover, dysfunction of vascular endothelium caused by hyperhomocysteinemia is important initiatory elements in the pristine development of atherosclerosis. Thus, this study was designed to investigate the rehabilitation of allitridi on homocysteinemia induced injury of endothelin (ET) and nitrogen oxide (NO) in rats. Fifty Wistar male rats were randomly divided into 5 groups: large dose garlic group (GL group), small dose garlic group (GS group), homocysteine group (HC group), folic acid group (AC group), and control group (NC group). The homocysteinemia model was established in rats through feeding induce by high dose methionine forage. At the same time, the rats of GL group and GS group were separately given allitridi 10mg/kg and 6mg/kg with abdominal injection. The sixth weekend, the blood of all rats was collected to determine the Hcy, ET and NO. The results indicated that (1) The Hcy of HC group and AC group were significantly higher than that of GL group, GS group and NC group (P<0.05-0.01). (2) The ET and ET/NO ratio of GL group and GS group were significantly lower, the NO were significantly higher, than that of HC group (P<0.05-0.01). We conclude that (1) Allitridi can significantly decrease Hcy and ET, increase NO and recover ET/NO balance in the rats with homocysteinemia; (2) It can protect and cure homocysteinemia and atherosclerosis.
机译:血液中血清同型半胱氨酸(Hcy)的升级水平是血管疾病的独立危险因素,例如动脉粥样硬化。 Hcy的低和中度升高可以将心血管和脑血管疾病患者的死亡风险降至六次。在冠心病(CHD)的发展中,高管细胞症的相对风险是23.9,远高于其他因素,如高血压疾病和高脂血症疾病。此外,由高管囊肿血症引起的血管内皮功能障碍是动脉粥样硬化的原始发育中的重要初始因素。因此,本研究旨在探讨allitridi对大鼠内皮素(Et)和氮氧化物(NO)的同型抗原血症诱导损伤的康复。将五十个Wistar雄性大鼠随机分为5组:大剂量大蒜组(GL组),小剂量大蒜组(GS组),同型半胱氨酸组(HC组),叶酸组(AC组)和对照组(NC组)。通过高剂量蛋氨酸饲料喂养,在大鼠中建立了同型抗原血症模型。同时,用腹部注射单独给予GL组和GS组的大鼠Allitridi 10mg / kg和6mg / kg。第六周末,收集所有大鼠的血液以确定Hcy,Et和No。结果表明(1)HC组和AC组的HCY显着高于GL组,GS组和NC组(P <0.05-0.01)。 (2)G1组和GS组的ET和ET / NO比显着降低,而不是HC组的效率显着高(P <0.05-0.01)。我们得出结论(1)allitridi可以显着降低Hcy和Et,增加否,并在具有同型抗原血症的大鼠中恢复ET / NO平衡; (2)它可以保护和治愈同型抗原性血症和动脉粥样硬化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号